A detailed history of Cinctive Capital Management LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 53,361 shares of RVMD stock, worth $3.01 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
53,361
Previous 22,931 132.7%
Holding current value
$3.01 Million
Previous $889,000 171.88%
% of portfolio
0.14%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.92 - $47.94 $1.12 Million - $1.46 Million
30,430 Added 132.7%
53,361 $2.42 Million
Q2 2024

Aug 14, 2024

SELL
$30.14 - $40.68 $459,032 - $619,556
-15,230 Reduced 39.91%
22,931 $889,000
Q1 2024

May 15, 2024

SELL
$26.56 - $33.55 $715,712 - $904,071
-26,947 Reduced 41.39%
38,161 $1.23 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $1.19 Million - $2.22 Million
65,108 New
65,108 $1.87 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.95B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.